{"schema_version":"secwatch.filing_event.v1","accession":"0001612630-26-000018","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.643549+00:00","generated_at":"2026-05-15T13:31:25.760608+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Joint Corp Q4 revenue $15.2M (+3.1% YoY); FY2025 net income $2.9M; guides FY2026 system-wide sales $519-552M","bullets":["Q4 revenue $15.2M (+3.1% YoY); net income from continuing ops $937K vs $909K.","FY2025 total revenue $54.9M; consolidated net income $2.9M vs net loss $5.8M in 2024.","Adjusted EBITDA from consolidated ops $13.0M (+13.9% YoY); FY2026 guidance $12.5-13.5M.","Refranchised 41 clinics in FY2025; 27 more in process; targets pure-play franchisor model.","Repurchased 1.3M shares for $11.3M in FY2025; $5.7M remaining on $12M buyback program."],"urls":{"canonical":"https://secwatch.observer/filing/0001612630-26-000018","json":"https://secwatch.observer/filing/0001612630-26-000018.json","markdown":"https://secwatch.observer/filing/0001612630-26-000018.md","text":"https://secwatch.observer/filing/0001612630-26-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/0001612630-26-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/jynt-20260312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:31:25.760608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"566fbf0b3076753b44c7db3586a2aabf005230d0","claim":"JOINT Corp reported the full year ended December 31, 2025 results: revenue $54.9 million, net income $2.9 million.","evidence_excerpt":"Full Year Revenues of $54.9 Million, Net Income of $2.9 Million and a 13.9% Increase in Adjusted EBITDA to $13.0 Million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/0001612630-26-000018-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2025"},{"label":"Revenue","value":"$54.9 million"},{"label":"Net income","value":"$2.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"83efebc7791861d173d1bb063ca5f355d65198cb","claim":"JOINT Corp reported the fourth quarter ended December 31, 2025 results: revenue $15.2 million, net income $1.0 million, EPS $0.07 per diluted share.","evidence_excerpt":"Revenue increased 3.1% to $15.2 million, compared to $14.7 million in the fourth quarter of 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000018/0001612630-26-000018-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2025"},{"label":"Revenue","value":"$15.2 million"},{"label":"Net income","value":"$1.0 million"},{"label":"EPS","value":"$0.07 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}